查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1606846

內分泌檢測市場：按類型、技術、適應症和最終用戶分類 - 2025-2030 年全球預測

Endocrine Testing Market by Type (Cortisol Test, Dehydroepiandrosterone Sulfate (DHEAS) Test, Estradiol (E2) Test), Technology (Clinical Chemistry, Immunoassay, Tandem Mass Spectroscopy), Indication, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年內分泌檢測市場價值為27.9億美元，預計2024年將達到30億美元，複合年成長率為8.24%，到2030年將達到48.6億美元。

內分泌測試分析體內荷爾蒙水平，這些荷爾蒙對於調節各種生理功能很重要。此測試對於診斷荷爾蒙失衡和相關疾病（例如甲狀腺疾病、糖尿病和腎上腺功能障礙）至關重要。內分泌檢測的應用涵蓋醫療保健、製藥和研究等許多領域，可以深入了解疾病機制和治療效果。最終用途範圍包括醫院、診斷實驗室和研究機構，這些測試是必不可少的。由於荷爾蒙失調的盛行率不斷增加、診斷技術的進步以及對早期檢測的日益重視，內分泌檢測市場正在不斷成長。主要促進成長因素包括檢測設備的技術創新、人口老化以及與文明病增加。目前的機會存在於個人化醫療工作以及將人工智慧整合到診斷工具中，這可以提高準確性並縮短週轉時間。然而，挑戰依然存在，包括先進測試的高成本、監管障礙以及發展中地區的准入有限。此外，測試結果的變化和缺乏標準化測試進一步使市場擴張變得複雜。對於業務成長，有一些成熟的創新領域，包括開發非侵入性檢測方法、就地檢驗解決方案以及改進數位健康平台以實現無縫資料共用和病人參與。研究還可以集中在了解細胞層面的荷爾蒙相互作用，這可能為治療性介入開闢新的途徑。市場動態具有競爭性和動態性，不斷推動測試靈敏度和特異性的提升。進入這一領域的公司需要專注於策略夥伴關係、研發投資以及開拓需求未滿足的市場，以抓住不斷成長的需求，同時應對現有挑戰。

主要市場統計
基準年[2023] 27.9億美元
預計年份 [2024] 30億美元
預測年份 [2030] 48.6億美元
複合年成長率（%） 8.24%

市場動態：揭示快速發展的內分泌檢測市場的關鍵市場洞察

供需的動態交互作用正在改變內分泌檢測市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助企業了解消費行為及其對製造業的影響。

  • 市場促進因素
    • 全球內分泌疾病盛行率上升
    • 提高對早期發現內分泌疾病重要性的認知
    • 擴大就地檢驗設備的採用
  • 市場限制因素
    • 內分泌檢測相關的高成本
  • 市場機會
    • 擴大分析和測試方法的技術進步
    • 完善醫療政策和報銷制度
  • 市場挑戰
    • 依賴傳統的荷爾蒙檢測法

波特五力：駕馭內分泌檢測市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點，避免潛在的挑戰，確保更強大的市場地位。

PESTLE分析：了解內分泌檢測市場的外部影響

外部宏觀環境因素對內分泌檢測市場的表現動態起著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解內分泌檢測市場的競爭狀況

對內分泌檢測市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來發現自己的競爭定位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位矩陣內分泌檢測市場供應商績效評估

FPNV定位矩陣是評估內分泌檢測市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議，規劃內分泌檢測市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對內分泌檢測市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 全球內分泌疾病盛行率上升
      • 提高對早期發現內分泌疾病重要性的認知
      • 擴大就地檢驗設備的引進範圍
    • 抑制因素
      • 內分泌檢測相關的高成本
    • 機會
      • 擴大分析和測試方法的技術進步
      • 完善醫療政策和報銷制度
    • 任務
      • 依賴傳統的荷爾蒙測試
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章內分泌檢測市場：依類型

  • 皮質醇測試
  • 硫酸去氫表雄酮（DHEAS）測試
  • 雌二醇（E2）測試
  • 濾泡刺激素(FSH) 測試
  • 人類絨毛膜促性腺激素分泌(hCG) 荷爾蒙測試
  • 胰島素測試
  • 黃體激素（LH）測試
  • 黃體酮測試
  • 催乳素測試
  • 睪酮測試
  • 甲狀腺刺激素（TSH）測試

第7章內分泌檢測市場：依技術分類

  • 臨床化學
  • 免疫檢測
  • 串聯式質譜法

第8章內分泌檢測市場適應症

  • 愛迪生氏症
  • 庫欣氏症
  • 糖尿病
  • 格雷夫茲病
  • 橋本氏甲狀腺炎

第9章內分泌檢測市場：依最終用戶分類

  • 診斷中心
  • 醫院
  • 調查機構

第10章 南北美洲內分泌檢測市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太地區內分泌檢測市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章 歐洲、中東、非洲內分泌檢測市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Abbott Laboratories
  • ACON Laboratories, Inc.
  • Agilent Technologies, Inc.
  • BioCheck Inc.
  • Biogenix Inc. Pvt. Ltd
  • bioMerieux SA
  • Blueprint Genetics Oy
  • Creative Diagnostics
  • Danaher Corporation
  • Diagnostic Automation/Cortez Diagnostics Inc.
  • DiaSorin SpA
  • Eagle Biosciences
  • EKF Diagnostics Holdings Plc
  • Eurofins Analytical Laboratories Inc.
  • Getein Biotech, Inc.
  • Laboratory Corporation of America Holdings
  • MP Biomedicals, LLC
  • Ortho-Clinical Diagnostics, Inc.
  • Quest Diagnostics Incorporated
  • Randox Laboratories Ltd.
  • Shenzhen New Industries Biomedical Engineering Co., Ltd.
  • Siemens Healthcare GmbH
  • Thermo Fisher Scientific Inc.
  • Trivitron Healthcare
Product Code: MRR-69324464D0E6

The Endocrine Testing Market was valued at USD 2.79 billion in 2023, expected to reach USD 3.00 billion in 2024, and is projected to grow at a CAGR of 8.24%, to USD 4.86 billion by 2030.

Endocrine testing involves the analysis of hormone levels in the body, which are critical in regulating a variety of physiological functions. This testing is essential for diagnosing hormonal imbalances and related conditions such as thyroid disorders, diabetes, and adrenal dysfunction. The application of endocrine testing spans numerous fields, including healthcare, pharmaceuticals, and research, offering insights into disease mechanisms and treatment efficacy. End-use scope covers hospitals, diagnostic laboratories, and research institutions where such testing is integral. The market for endocrine testing is growing due to increasing prevalence of hormonal disorders, advancements in diagnostic technologies, and a rising emphasis on early detection. Key growth drivers include technological innovations in testing equipment, an aging population, and a rising incidence of lifestyle-related diseases. Current opportunities exist in the form of personalized medicine initiatives and the integration of artificial intelligence in diagnostic tools, which can enhance accuracy and reduce turnaround times. However, challenges persist, including high costs of advanced testing methods, regulatory hurdles, and limited access in developing regions. Moreover, variability in test results and the lack of standardized testing further complicate market expansion. For business growth, areas ripe for innovation include the development of non-invasive testing methods, point-of-care testing solutions, and improving digital health platforms for seamless data sharing and patient engagement. Research can also focus on understanding hormone interactions at a cellular level, which may open avenues for novel therapeutic interventions. The nature of the endocrine testing market is competitive and dynamic, with a continual push towards improved sensitivity and specificity of tests. Businesses venturing into this field should focus on strategic partnerships, investing in R&D, and exploring markets with unmet needs to capitalize on growing demand while addressing existing challenges.

KEY MARKET STATISTICS
Base Year [2023] USD 2.79 billion
Estimated Year [2024] USD 3.00 billion
Forecast Year [2030] USD 4.86 billion
CAGR (%) 8.24%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Endocrine Testing Market

The Endocrine Testing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising prevalence of endocrine disorders globally
    • Increased awareness of the importance of early detection of endocrine disorders
    • Growing adoption of point-of-care testing devices
  • Market Restraints
    • High cost associated with endocrine tests
  • Market Opportunities
    • Expanding technological advancements in assay and testing methods
    • Increasing improvements in healthcare policies and reimbursement systems
  • Market Challenges
    • Reliance on conventional hormone assays

Porter's Five Forces: A Strategic Tool for Navigating the Endocrine Testing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Endocrine Testing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Endocrine Testing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Endocrine Testing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Endocrine Testing Market

A detailed market share analysis in the Endocrine Testing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Endocrine Testing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Endocrine Testing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Endocrine Testing Market

A strategic analysis of the Endocrine Testing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Endocrine Testing Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, ACON Laboratories, Inc., Agilent Technologies, Inc., BioCheck Inc., Biogenix Inc. Pvt. Ltd, bioMerieux SA, Blueprint Genetics Oy, Creative Diagnostics, Danaher Corporation, Diagnostic Automation/Cortez Diagnostics Inc., DiaSorin S.p.A., Eagle Biosciences, EKF Diagnostics Holdings Plc, Eurofins Analytical Laboratories Inc., Getein Biotech, Inc., Laboratory Corporation of America Holdings, MP Biomedicals, LLC, Ortho-Clinical Diagnostics, Inc., Quest Diagnostics Incorporated, Randox Laboratories Ltd., Shenzhen New Industries Biomedical Engineering Co., Ltd., Siemens Healthcare GmbH, Thermo Fisher Scientific Inc., and Trivitron Healthcare.

Market Segmentation & Coverage

This research report categorizes the Endocrine Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Cortisol Test, Dehydroepiandrosterone Sulfate (DHEAS) Test, Estradiol (E2) Test, Follicle Stimulating Hormone (FSH) Test, Human Chorionic Gonadotropin (hCG) Hormone Test, Insulin Test, Luteinizing Hormone (LH) Test, Progesterone Test, Prolactin Test, Testosterone Test, and Thyroid Stimulating Hormone (TSH) Test.
  • Based on Technology, market is studied across Clinical Chemistry, Immunoassay, and Tandem Mass Spectroscopy.
  • Based on Indication, market is studied across Addison's Disease, Cushing's Disease, Diabetes, Graves' Disease, and Hashimoto Thyroiditis.
  • Based on End-User, market is studied across Diagnostic Centers, Hospitals, and Research Institutes.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of endocrine disorders globally
      • 5.1.1.2. Increased awareness of the importance of early detection of endocrine disorders
      • 5.1.1.3. Growing adoption of point-of-care testing devices
    • 5.1.2. Restraints
      • 5.1.2.1. High cost associated with endocrine tests
    • 5.1.3. Opportunities
      • 5.1.3.1. Expanding technological advancements in assay and testing methods
      • 5.1.3.2. Increasing improvements in healthcare policies and reimbursement systems
    • 5.1.4. Challenges
      • 5.1.4.1. Reliance on conventional hormone assays
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Endocrine Testing Market, by Type

  • 6.1. Introduction
  • 6.2. Cortisol Test
  • 6.3. Dehydroepiandrosterone Sulfate (DHEAS) Test
  • 6.4. Estradiol (E2) Test
  • 6.5. Follicle Stimulating Hormone (FSH) Test
  • 6.6. Human Chorionic Gonadotropin (hCG) Hormone Test
  • 6.7. Insulin Test
  • 6.8. Luteinizing Hormone (LH) Test
  • 6.9. Progesterone Test
  • 6.10. Prolactin Test
  • 6.11. Testosterone Test
  • 6.12. Thyroid Stimulating Hormone (TSH) Test

7. Endocrine Testing Market, by Technology

  • 7.1. Introduction
  • 7.2. Clinical Chemistry
  • 7.3. Immunoassay
  • 7.4. Tandem Mass Spectroscopy

8. Endocrine Testing Market, by Indication

  • 8.1. Introduction
  • 8.2. Addison's Disease
  • 8.3. Cushing's Disease
  • 8.4. Diabetes
  • 8.5. Graves' Disease
  • 8.6. Hashimoto Thyroiditis

9. Endocrine Testing Market, by End-User

  • 9.1. Introduction
  • 9.2. Diagnostic Centers
  • 9.3. Hospitals
  • 9.4. Research Institutes

10. Americas Endocrine Testing Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Endocrine Testing Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Endocrine Testing Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. ACON Laboratories, Inc.
  • 3. Agilent Technologies, Inc.
  • 4. BioCheck Inc.
  • 5. Biogenix Inc. Pvt. Ltd
  • 6. bioMerieux SA
  • 7. Blueprint Genetics Oy
  • 8. Creative Diagnostics
  • 9. Danaher Corporation
  • 10. Diagnostic Automation/Cortez Diagnostics Inc.
  • 11. DiaSorin S.p.A.
  • 12. Eagle Biosciences
  • 13. EKF Diagnostics Holdings Plc
  • 14. Eurofins Analytical Laboratories Inc.
  • 15. Getein Biotech, Inc.
  • 16. Laboratory Corporation of America Holdings
  • 17. MP Biomedicals, LLC
  • 18. Ortho-Clinical Diagnostics, Inc.
  • 19. Quest Diagnostics Incorporated
  • 20. Randox Laboratories Ltd.
  • 21. Shenzhen New Industries Biomedical Engineering Co., Ltd.
  • 22. Siemens Healthcare GmbH
  • 23. Thermo Fisher Scientific Inc.
  • 24. Trivitron Healthcare

LIST OF FIGURES

  • FIGURE 1. ENDOCRINE TESTING MARKET RESEARCH PROCESS
  • FIGURE 2. ENDOCRINE TESTING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL ENDOCRINE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS ENDOCRINE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS ENDOCRINE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES ENDOCRINE TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES ENDOCRINE TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC ENDOCRINE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC ENDOCRINE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ENDOCRINE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA ENDOCRINE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. ENDOCRINE TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. ENDOCRINE TESTING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. ENDOCRINE TESTING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL ENDOCRINE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. ENDOCRINE TESTING MARKET DYNAMICS
  • TABLE 7. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY CORTISOL TEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY DEHYDROEPIANDROSTERONE SULFATE (DHEAS) TEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY ESTRADIOL (E2) TEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY FOLLICLE STIMULATING HORMONE (FSH) TEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY HUMAN CHORIONIC GONADOTROPIN (HCG) HORMONE TEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY INSULIN TEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY LUTEINIZING HORMONE (LH) TEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY PROGESTERONE TEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY PROLACTIN TEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY TESTOSTERONE TEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY THYROID STIMULATING HORMONE (TSH) TEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY CLINICAL CHEMISTRY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY TANDEM MASS SPECTROSCOPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY ADDISON'S DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY CUSHING'S DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY DIABETES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY GRAVES' DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY HASHIMOTO THYROIDITIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS ENDOCRINE TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 40. ARGENTINA ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 41. ARGENTINA ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 44. BRAZIL ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 45. BRAZIL ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 48. CANADA ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 49. CANADA ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. MEXICO ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 52. MEXICO ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 53. MEXICO ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 58. UNITED STATES ENDOCRINE TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 59. ASIA-PACIFIC ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC ENDOCRINE TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 64. AUSTRALIA ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. AUSTRALIA ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 66. AUSTRALIA ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 67. AUSTRALIA ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 68. CHINA ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. CHINA ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 70. CHINA ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 71. CHINA ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 72. INDIA ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. INDIA ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 74. INDIA ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 75. INDIA ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 76. INDONESIA ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. INDONESIA ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 78. INDONESIA ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 79. INDONESIA ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 80. JAPAN ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. JAPAN ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 82. JAPAN ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 83. JAPAN ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 84. MALAYSIA ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. MALAYSIA ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 86. MALAYSIA ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 87. MALAYSIA ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 88. PHILIPPINES ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. PHILIPPINES ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 90. PHILIPPINES ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 91. PHILIPPINES ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 92. SINGAPORE ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. SINGAPORE ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 94. SINGAPORE ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 95. SINGAPORE ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. SOUTH KOREA ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. SOUTH KOREA ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 98. SOUTH KOREA ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 99. SOUTH KOREA ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 100. TAIWAN ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. TAIWAN ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 102. TAIWAN ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 103. TAIWAN ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 104. THAILAND ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. THAILAND ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 106. THAILAND ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 107. THAILAND ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 108. VIETNAM ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. VIETNAM ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 110. VIETNAM ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 111. VIETNAM ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 112. EUROPE, MIDDLE EAST & AFRICA ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. EUROPE, MIDDLE EAST & AFRICA ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 114. EUROPE, MIDDLE EAST & AFRICA ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 115. EUROPE, MIDDLE EAST & AFRICA ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 116. EUROPE, MIDDLE EAST & AFRICA ENDOCRINE TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 117. DENMARK ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. DENMARK ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 119. DENMARK ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 120. DENMARK ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 121. EGYPT ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. EGYPT ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 123. EGYPT ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 124. EGYPT ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 125. FINLAND ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. FINLAND ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 127. FINLAND ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 128. FINLAND ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 129. FRANCE ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. FRANCE ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 131. FRANCE ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 132. FRANCE ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 133. GERMANY ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. GERMANY ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 135. GERMANY ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 136. GERMANY ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 137. ISRAEL ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. ISRAEL ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 139. ISRAEL ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 140. ISRAEL ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 141. ITALY ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. ITALY ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 143. ITALY ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 144. ITALY ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 145. NETHERLANDS ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. NETHERLANDS ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 147. NETHERLANDS ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 148. NETHERLANDS ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 149. NIGERIA ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. NIGERIA ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 151. NIGERIA ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 152. NIGERIA ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 153. NORWAY ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 154. NORWAY ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 155. NORWAY ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 156. NORWAY ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 157. POLAND ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 158. POLAND ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 159. POLAND ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 160. POLAND ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 161. QATAR ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 162. QATAR ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 163. QATAR ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 164. QATAR ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 165. RUSSIA ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 166. RUSSIA ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 167. RUSSIA ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 168. RUSSIA ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 169. SAUDI ARABIA ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 170. SAUDI ARABIA ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 171. SAUDI ARABIA ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 172. SAUDI ARABIA ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 173. SOUTH AFRICA ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 174. SOUTH AFRICA ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 175. SOUTH AFRICA ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 176. SOUTH AFRICA ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 177. SPAIN ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 178. SPAIN ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 179. SPAIN ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 180. SPAIN ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 181. SWEDEN ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 182. SWEDEN ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 183. SWEDEN ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 184. SWEDEN ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 185. SWITZERLAND ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 186. SWITZERLAND ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 187. SWITZERLAND ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 188. SWITZERLAND ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 189. TURKEY ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 190. TURKEY ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 191. TURKEY ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 192. TURKEY ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 193. UNITED ARAB EMIRATES ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 194. UNITED ARAB EMIRATES ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 195. UNITED ARAB EMIRATES ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 196. UNITED ARAB EMIRATES ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 197. UNITED KINGDOM ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 198. UNITED KINGDOM ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 199. UNITED KINGDOM ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 200. UNITED KINGDOM ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 201. ENDOCRINE TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 202. ENDOCRINE TESTING MARKET, FPNV POSITIONING MATRIX, 2023